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pulmonary emphysema; airway reversibility; 1-s forced expiratory volume; forced vital capacity; high-resolution computed tomography; chronic obstructive pulmonary disease REVERSIBILITY OF AIRFLOW OBSTRUCTION is generally defined by an increment of the 1-s forced expiratory volume (FEV 1 ) beyond its short-term natural variability after inhalation of a standard dose of a bronchodilator (3, 13) . In a number of patients with severe chronic obstructive pulmonary disease (COPD), forced vital capacity (FVC) remarkably increases in response to bronchodilator administration whereas FEV 1 remains substantially unchanged (4, 8, 12, 14) . This isolated volume response is generally taken as an indisputable sign of bronchodilatation (3, 13) , but the underlying mechanisms are still unknown.
In the normal lung, the airways and lung parenchyma are interdependent in such a way that airway caliber monotonically increases with increasing lung volume. In the emphysematous lung, the caliber of small airways changes less than in the normal lung during changes in lung volume (20) , and peripheral airway resistance may paradoxically increase when lung volume increases (18) . A lack of increase or even a decrease in airway caliber with lung inflation may be the result of longitudinal traction of airways not supported by the radial traction by parenchymal tethering. Furthermore, Verbeken et al. (19) advanced the hypothesis of space competition, by which enlarged emphysematous air spaces would compress the adjacent small airways more at high than at low lung volumes, thus blunting or even reversing the change in airway caliber during lung inflation. We hypothesized that these mechanisms may explain, at least in part, the isolated volume response to bronchodilators. We reasoned that, at high lung volume, flow cannot increase after bronchodilator administration because the caliber of small airways is mainly dependent on the effects of airway-toparenchymal interdependence. During deflation, the airway caliber would become progressively more dependent on smooth muscle tone and, by inference, sensitive to bronchodilator drugs. As a consequence, the FEV 1 , which in the obstructed patients mainly reflects events occurring at relatively high lung volumes, would change very little, whereas FVC, which is dependent on the degree of flow limitation at low lung volume, would significantly increase.
To test this hypothesis, we compared lung function with high-resolution and spiral computed tomography data in a group of COPD patients with isolated volume response to an inhaled bronchodilator. A group of patients with both FEV 1 and FVC response to the bronchodilator served as controls. We predicted an association between the isolated volume response to the bronchodilator, the radiological extension of emphysema, and the lack (or reversal) of increase in smallairway caliber with lung inflation.
METHODS

Subjects.
Ten male patients affected by COPD took part in the study. The diagnosis was based on the criteria of the American Thoracic Society (2) . All patients were familiar with pulmonary function tests. They were required to abstain from short-acting bronchodilators for at least 12 h, to be in stable clinical conditions, and not to have suffered from respiratory exacerbations in the previous 4 wk. To be included, patients had to respond to a standard dose of an inhaled bronchodilator (see Study design) with an increase of FVC alone (FVC responders, n ϭ 5) or both FEV 1 and FVC (FVC-FEV 1 responders, n ϭ 5) beyond their spontaneous variabilities. The study was approved by the local ethics committee, and the patients signed an informed consent.
Study design. The patients attended the clinic in the midafternoon of 3 separate days. On the first occasion, baseline spirometry and lung volumes were measured. These measurements plus single-breath diffusion capacity for carbon monoxide (DL CO ) were repeated 30 min after inhalation of salbutamol (200 µg through a metered-dose inhaler with large spacer). Within a week, the patients returned to the lung function laboratory at the same time of the day to have the bronchodilatation response to salbutamol reassessed. On this occasion, lung elastic recoil was determined in those patients who consented. Finally, all patients attended the department of radiology for imaging studies.
Lung function measurements. A Vmax 22 system and an Autobox V6200 (SensorMedics, Yorba Linda, CA) were used to measure lung function.
For spirometry, mouth flow was measured through a mass flow sensor, and volume was obtained by numerical integration of the flow signal. After at least four stable tidal breaths, patients were asked to exhale slowly to residual volume (RV) and then to inspire forcefully to total lung capacity (TLC). This maneuver was immediately followed by a forced expiration to RV. The forced inspiratory flow at 50% of FVC (FIF 50 ) and forced expiratory flows at 50% (FEF 50 ) and 25% (FEF 25 ) of FVC were measured on flow-volume curves. Forced expiratory maneuvers were repeated until reproducible values of FEV 1 and FVC were obtained (3) .
Lung volumes were measured while the patients were sitting in a body plethysmograph and panting against a closed shutter at a frequency Ͻ1 Hz with their cheeks supported. TLC was obtained as the sum of thoracic gas volume and inspiratory capacity measured soon after the opening of the shutter. Predicted values for spirometry and lung volumes were from Quanjer et al. (13) .
Pleural pressure was estimated from the pressure measured (143PCO5D, Honeywell, Minneapolis, MN) in the lower third of the esophagus by a 10-cm-long latex balloon filled with ϳ1 ml of air while the patient was in a sitting position. Transpulmonary pressure (Ptp) was the difference between pleural pressure and mouth pressure. Placement of the balloon was considered correct if Ptp did not change when an expiratory effort was made against a partially closed airway and cardiac oscillations were minimal. Three satisfactory Ptp measurements were taken during breath hold at TLC, and their average was used as an estimate of lung elastic recoil pressure (Pel TLC ).
Single-breath DL CO was measured by using the method described by Huang and MacIntyre (9) and predicted values were taken from Cotes et al. (6) .
Imaging techniques. A third-generation, continuous-rotation computerized tomograph with volume acquisition extendable to 24 s (Somaton Plus, Siemens, Erlangen, Germany) was used. Qualitative evaluation of type and distribution of emphysema was made by high-resolution computed tomography. During a breath hold at TLC, three axial scans were taken at the levels of aortic arch, tracheal carina, and pulmonary veins, respectively. Quantitative evaluation of emphysema was based on three additional scans, taken at the same levels as before while the patient was holding his breath at RV. By using an appropriate software (Siemens) and the ''density mask'' method, the percentage of pixels with density less than Ϫ900 Hounsfield units (HU) was calculated. This percentage represents fairly well the proportion of lung tissue affected by emphysema (11) . Centrilobular emphysema was defined as a prevalence of lucent holes within the lobules and panlobular emphysema as the presence of widespread lowdensity areas with narrow vessels.
Bronchial caliber was measured by using 1-mm-thick spiral scans taken in the most emphysematous areas of the lung. If emphysema was uniformly distributed, scans were taken in the middle fields with the plane tilted at 25°, which makes the majority of bronchi fairly parallel to the scanning plane. Volumetric scans were taken during 20-to 24-s breath hold at TLC and at functional residual capacity (FRC). Care was taken to coach the patients before the study on how to perform the required respiratory maneuvers. For each volumetric scan, 30-40 contiguous, 1-mm thick axial images were obtained (15) , which allowed identification of 2 to 4 small bronchi. These bronchi were located between 15 and 25 mm from the pleural surface, they had a caliber ranging from 0.5 to 2 mm, and they ran parallel to the scanning plane so that they could be examined in longitudinal section. The same bronchus was identified on two images obtained at FRC and TLC, based on the lung segment to which it belonged, its morphology, orientation, and anatomic relations to the arterial system. All airways identified on both images were considered, and measurements were made by an investigator unaware of the bronchodilator response. The caliber of each bronchus was estimated by software from the linear distance between two points of its opposing sides, by using a cursor manually positioned on the screen. Two to three measure- 
RESULTS
Pulmonary function. At baseline (Table 1) , the degree of airflow obstruction was markedly greater in FVC responders than in FVC-FEV 1 responders. FEF 50 was lower in FVC responders than in FVC-FEV 1 responders (P Ͻ 0.02), whereas FIF 50 was not significantly different in the two groups. This resulted in a significantly (P Ͻ 0.02) greater FIF 50 -to-FEF 50 ratio in FVC responders (11.6 Ϯ 3.0) than in FVC-FEV 1 responders (5.7 Ϯ 0.5); one patient of each group was not able to perform correctly the forced inspiratory maneuver. The duration of forced expiration was similar in both groups. Also similar were TLC, FRC, and RV. Pel TLC was determined in three FVC responders (14.9 Ϯ 2.04 cmH 2 O, or 64 Ϯ 12% of predicted) and in only one FVC-FEV 1 responder (18 cmH 2 O, or 81% of predicted); the remaining subjects did not tolerate the esophageal balloon. DL CO was significantly lower in FVC responders than in FVC-FEV 1 responders; one FVC responder and two FVC-FEV 1 responders were not able to perform the correct maneuver.
After salbutamol inhalation (Table 2) , FVC increased in both groups beyond its variability range. In contrast, FEV 1 increased by 6 Ϯ 2% in FVC responders and by 18 Ϯ 3% in FVC-FEV 1 responders. In all subjects of either group, the pattern of response was reproducible (Table 3 ). In FVC responders but not in FVC-FEV 1 responders, the forced expiration was completed in a slightly longer time than before bronchodilatation (1.9 Ϯ 1.1 s, P Ͻ 0.05), but this accounted for only 0.23 Ϯ 0.22 liter, i.e., about one-third of the increase of FVC. In neither group was TLC changed significantly after inhalation of salbutamol. Examples of flow-volume curves at control and after salbutamol inhalation are shown in Fig. 1 . Imaging data. The extent of emphysema was significantly greater in FVC responders than in FVC-FEV 1 responders ( Table 4 ). The diameter of the small airways was similar in the two groups at FRC but significantly smaller (P Ͻ 0.05) in FVC responders than in FVC-FEV 1 responders at TLC. With lung inflation from FRC to TLC, the caliber of small airways increased in all FVC-FEV 1 responders and in one FVC responder, whereas in the remaining four FVC responders it remained unchanged (2 cases) or decreased (2 cases). Typical spiral computed tomography scans of small airways at FRC and TLC for one FVC responder and one FVC-FEV 1 responder are shown in Fig. 2 .
Relationships among variables. Salbutamol-induced changes in FEV 1 (Fig. 3) were negatively correlated with the extent of emphysema (r ϭ Ϫ0.89; P Ͻ 0.001) and the ratio FIF 50 /FEF 50 (r ϭ Ϫ0.92; P Ͻ 0.01) but positively correlated with DL CO (r ϭ 0.96; P Ͻ 0.001), Pel TLC (r ϭ 0.95; P ϭ 0.054), and the absolute increment in small-airway diameter between FRC and TLC (r ϭ 0.63; P Ͻ 0.05). The caliber of small airways increased proportionally to the cube root of the increase in lung volume from FRC to TLC in FVC-FEV 1 responders (r ϭ 0.90; P Ͻ 0.05) but not in FVC responders (Fig. 4) . The extent of emphysema was significantly correlated with both DL CO (r ϭ Ϫ0.85; P Ͻ 0.05) and Pel TLC (r ϭ Ϫ0.97; P Ͻ 0.05).
DISCUSSION
The hypothesis tested in the present study was that the isolated volume response to bronchodilators is a characteristic of severe emphysema and may be in part explained by abnormal effects of lung inflation on airway caliber. The findings seem to support this hypothesis because 1) there was an inverse relationship between salbutamol-induced increments in FEV 1 and various indexes of emphysema, in spite of conspicuous increments of FVC, and 2) the airway caliber increased with lung volume in all FVC-FEV 1 responders but decreased or remained unchanged in most FVC responders.
Comments on methodology. The extent of emphysema was inferred from the percent area in the six hemislices with attenuation values less than Ϫ900 HU at the end of full expiration. Although we might have missed some areas of the lungs where the disease was more diffuse and severe, we believe that our estimate of emphysema was fairly good because it correlated well with both Pel TLC and DL CO .
Measurements of airway caliber were taken on longitudinal scans. We think this method preferable to orthogonal scanning because it allows a better tracking of airways at different lung volumes on the basis of their relationships with the surrounding anatomical structures and it permits measurements at multiple sites along the course of the same airway. Moreover, measurements of airway caliber on orthogonal scans may be unreliable when bronchial sections are too oblique to the scanning plane (5). Three patients were able to hold their breath at TLC for only 20 s instead of the requested 24 s, which necessarily limited the number of scans. In these cases, only two airways could be identified. Despite the inherent limits of the imaging technique, the observation that the measured changes in airway caliber were always consistent within patients makes us confident that the method used yielded a reliable assessment of changes in airway caliber with lung inflation.
The relationship between changes in airway diameter and lung volume was studied by comparing imaging data obtained in a supine position with spirometric data measured in a sitting position. In healthy subjects, the FRC usually decreases from sitting to supine position, whereas TLC remains nearly constant (1) . Although the effect of posture on FRC may be lower in obstructed patients than in normal subjects, it is possible that changes in airway diameter relative to changes in lung volume were overestimated.
Finally, airway dimensions measured during breath hold were related to flows measured during forced expiration. Thus any effect of nonuniform lung emptying could not be evaluated.
Comments on results. The isolated volume response to bronchodilators has been recognized for a long time (3, 4, 8, 12, 14) , but the underlying mechanisms have never been completely elucidated. The FEV 1 is determined by airflow at high to medium lung volumes, whereas the FVC is determined by airway closure or extreme flow limitation at low lung volumes. Therefore, a change of FVC without a concomitant change of FEV 1 after administration of a bronchodilator agent suggests that the airway smooth muscle tone is a major determi- nant of airway caliber at low but not at high lung volumes.
During a forced expiratory maneuver, flow limitation occurs at the point (choke point) at which the velocity of air matches the velocity of wave propagation in the airway wall (7) . The magnitude of maximal flow is directly related to airway caliber and to the elastance of the airway wall at choke point.
A reduction of airway smooth muscle tone after inhalation of a bronchodilator can increase airway caliber, but it may also decrease airway wall stiffness. In emphysema, airway stiffness may be decreased (10) , and a further decrease of it by removal of airway smooth muscle tone could prevent flow from increasing after bronchodilatation. Although no inference about airway compressibility is possible with the present data, the higher ratio of FIF 50 to FEF 50 in FVC responders than in FVC-FEV 1 responders and the significant negative correlation between this ratio and the percent increase of FEV 1 suggest a role for this mechanism.
Another reason for an isolated volume response may be related to an abnormal effect of lung inflation on airway caliber. In emphysema, the distending force acting on the small airway walls may not be sufficient to fully dilate them so that expiratory flow may be limited in peripheral airways even at high lung volumes, irrespective of airway smooth muscle tone. Under these conditions, the airway smooth muscle tone may not be the major determinant of flow at high lung volume, thus making bronchodilator agents ineffective. With lung emptying, the effect of airway-to-parenchymal interdependence becomes progressively less important, and flow will be mainly dependent on airway caliber as determined by airway smooth muscle tone.
In the present study, the caliber of small airways increased proportionally to the cube root of lung volume, as theoretically predicted for normal lung (16) , in all FVC-FEV 1 responders, but it remained unchanged or decreased in FVC responders. A decrease in airway caliber with lung inflation may be the result of longitudinal traction in the absence of the radial support provided by the lung elastic recoil on airway walls. Furthermore, Verbeken et al. (17, 19) recently proposed a theory according to which the airways, which are located within interlobular septa, can be compressed by enlarged air spaces. The precise mechanism for such a space competition is unknown, but small noncartilaginous airways might be compressed because the two layers of the septa containing them get too close when stretched or because they are squeezed by the abutting emphysematous air spaces (19) . If airway caliber decreases with lung inflation in most of the lung, then we may assume that expiratory flow can be limited in the small airways even at high lung volume either before or after bronchodilatation. If elastic recoil does not change after salbutamol inhalation, then such a constant highflow resistance could explain the lack of increase in flow after bronchodilatation over the first liter below TLC.
In FVC responders, there was a small but significant increase in the duration of the forced expiratory maneuver after bronchodilatation, but its magnitude was such that it could explain only a minor part (ϳ30%) of the observed increase of FVC.
Another hypothetical cause for flow to be prevented from increasing at high lung volumes after bronchodilatation could be an excess of thoracic gas compression occurring during forced expiration. This explanation, however, should assume a larger lung volume or an increase of the force of the expiratory muscles in FVC responders than in FVC-FEV 1 responders. Although we have no data to reject this mechanism, we feel that it is unlikely because TLC was not significantly different in the two groups yet tended to be larger in FVC-FEV 1 responders than in FVC responders.
Conclusions. The results of the present study suggest that isolated volume response to bronchodilators is a characteristic of severe emphysema involving more than 40% of lung parenchyma. An altered effect of lung inflation on airway caliber, due either to loss of lung elastic recoil or to space competition, may be the mechanism making airway caliber independent of airways smooth muscle tone at high lung volume, thus explaining at least in part the lack of sensitivity to bronchodilatation as assessed by changes in FEV 1 .
